We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ESALF market cap is 8.62B. The company's latest EPS is JPY 147.9085 and P/E is 0.20.
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 697.09B | 647.39B | 770.87B | 752.72B | 753.75B |
| Operating Income | 122.8B | 53.22B | 53.75B | 40.04B | 53.41B |
| Net Income | 121.77B | 42.12B | 47.95B | 55.43B | 42.41B |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 1.06T | 1.09T | 1.24T | 1.26T | 1.39T |
| Total Liabilities | 359.51B | 362.07B | 467.78B | 440.78B | 494.83B |
| Total Equity | 702.63B | 727.94B | 771.53B | 822.57B | 898.97B |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 102.78B | 73.85B | 117.59B | -1.77B | 55.99B |
| Investing | -27.63B | -36.87B | -28.85B | -22.72B | -25.32B |
| Financing | -103.53B | -55.91B | -48.97B | -24.52B | -22.72B |
| Market Cap | 8.62B |
| Price to Earnings Ratio | 0.20 |
| Price to Sales Ratio | 0.01 |
| Price to Cash Ratio | 0.03 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | - |
| Shares Outstanding | 286.7M |
| Average Volume (1 week) | 1.31k |
| Average Volume (1 Month) | 9.24k |
| 52 Week Change | -41.55% |
| 52 Week High | 52.97 |
| 52 Week Low | 28.51 |
| Spread (Intraday) | 3.95 (12.14%) |
| Company Name | Eisai Co Ltd (PK) |
| Address |
4-6-10 koishikawa bunkyo, tokyo 112-8088 |
| Website | https://www.eisai.co.jp |
| Industry | pharmaceutical other prescript (H28) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
